Screening all hospitalized patients with HIV for tuberculosis (TB) using urine tests would improve life expectancy and be cost-effective in Malawi and South Africa. These findings from an international team of investigators ...
Jan 22, 2019
0
50
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...
Nov 21, 2017
0
282
Two landmark clinical trials reported at the Union Conference in Paris showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB.
Nov 16, 2023
0
24
About 1.5 million people died of tuberculosis (TB) in 2017, making it the most lethal infectious disease worldwide. A growing rise in drug-resistant TB is a major obstacle to successfully treating the illness.
May 7, 2019
0
334
For most people in the United States, the only awareness of tuberculosis (TB) may be the skin patch test required to work or volunteer in schools or health care facilities. But that could change during the pandemic.
Sep 23, 2020
0
13
A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much ...
Feb 11, 2019
0
2
New research from the University of Dundee has revealed that the worldwide tuberculosis (TB) epidemic is leaving a legacy of chronic lung disease.
Aug 9, 2019
0
1
Even though annual deaths from AIDS are coming down—from a peak of 1.9 million in 2004 to 690,000 in 2020—that's still way too many. In 2020, 214,000 people with AIDS died of tuberculosis (TB), though only about 50% were ...
Feb 10, 2022
0
3
Researchers have discovered that over-the-counter drugs commonly used to treat heartburn could shorten the treatment of tuberculosis (TB). These drugs could also reduce the chances of the bacteria that causes TB from becoming ...
Feb 6, 2023
0
76
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Sep 10, 2012
4
0
